Chronic intraperitoneal injection of polyethylene glycol 200 in mice induces hippocampal neuroinflammation

References

• Abdou, S.A., and Henderson, P.W., 2019. Fusogens: chemical agents that can rapidly restore function after nerve injury. Journal of Surgical Research, 233, 36–40.
   PubMed Web of Science ®Google Scholar
• Anderson, M.A., Ao, Y., and Sofroniew, M.V., 2014. Heterogeneity of reactive astrocytes. Neuroscience Letters, volume 565, 0, 23–29.
   Google Scholar
• Assal, C., and Watson, P.Y., 2006. Angioedema as a hypersensitivity reaction to polyethylene glycol oral electrolyte solution. Gastrointestinal Endoscopy, 64 (2), 294–295.
   PubMed Web of Science ®Google Scholar
• Bachstetter, A.D., et al., Nelson, P.T., 2015. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathologica Communications, 3, 32.
   PubMed Web of Science ®Google Scholar
• Bjugstad, K.B., et al., 2010. Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: an analysis of the glial response across space and time. Journal of Biomedical Materials Research Part A, 95A (1), 79–91.
   Web of Science ®Google Scholar
• Boche, D., Perry, V.H., and Nicoll, J. A. R., 2013. Review: activation patterns of microglia and their identification in the human brain. Neuropathology and Applied Neurobiology, 39 (1), 3–18.
   PubMed Web of Science ®Google Scholar
• Bruinsma, B.G., et al., 2015. Supercooling preservation and transplantation of the rat liver. Nature Protocols, 10 (3), 484–494.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan, A., et al., 2003. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Annals of Oncology, 14 (9), 1430–1437.
   PubMed Web of Science ®Google Scholar
• Couturier, J., et al., 2012. Pharmacological Inhibition of PKR in APPswePS1dE9 Mice Transiently Prevents Inflammation at 12 Months of Age but Increases Aβ42 Levels in the Late Stages of the Alzheimer’s Disease. Current Alzheimer Research, 9 (3), 344–360. 10.2174/156720512800107582
   PubMed Web of Science ®Google Scholar
• Damjanac, M., et al., 2007. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Research, 1128 (1), 40–49. 10.1016/j.brainres.2006.05.050 17125750
   PubMed Web of Science ®Google Scholar
• Dinarello, C.A., 1996. Biologic basis for interleukin-1 in disease. Blood, 87 (6), 2095–2147.
   PubMed Web of Science ®Google Scholar
• Dossi, E., Vasile, F., and Rouach, N., 2018. Human astrocytes in the diseased brain. Brain Research Bulletin, 136, 139–156.
   PubMed Web of Science ®Google Scholar
• Eng, L.F., and Ghirnikar, R.S., 1994. GFAP and astrogliosis. Brain Pathology (Pathology), 4 (3), 229–237.
   PubMed Web of Science ®Google Scholar
• François, A., et al., 2014. Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice. Journal of Neuroinflammation, 11, 139 10.1186/s12974-014-0139-xPMC: 25158693
   PubMed Web of Science ®Google Scholar
• Gao, P., et al., 2016a. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors. Oncotarget, 7 (3), 2855–2866.
   PubMedGoogle Scholar
• Gao, S., et al., 2016b. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment. Journal of Controlled Release, 243, 357–369.
   PubMed Web of Science ®Google Scholar
• Garaschuk, O., and Verkhratsky, A., 2019. Physiology of microglia. Methods in Molecular Biology (Clifton, N.J.), 2034, 27–40.
   PubMedGoogle Scholar
• Gomez-Nicola, D., and Perry, V.H., 2015. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 21 (2), 169–184.
   PubMed Web of Science ®Google Scholar
• Heneka, M.T., 2019. Microglia take centre stage in neurodegenerative disease. Nature Reviews Immunology, 19 (2), 79–80.
   PubMed Web of Science ®Google Scholar
• Heneka, M.T., et al., Golenbock, D.T., 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature, 493 (7434), 674–678.
   PubMed Web of Science ®Google Scholar
• Iesavand, H., et al., 2019. Investigation on absorption and release of mercaptopurine anticancer drug from modified polylactic acid as polymer carrier by molecular dynamic simulation. Materials Science & Engineering. C, Materials for Biological Applications, 105, 110010.
   PubMed Web of Science ®Google Scholar
• Ivens, I.A., et al., 2015. PEGylated biopharmaceuticals: current experience and considerations for nonclinical development. Toxicologic Pathology, 43 (7), 959–983.
   PubMed Web of Science ®Google Scholar
• Johanson, C., et al., 2011. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicologic Pathology, 39 (1), 186–212.
   PubMed Web of Science ®Google Scholar
• Knop, K., et al., 2010. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angewandte Chemie International Edition), 49 (36), 6288–6308.
   PubMed Web of Science ®Google Scholar
• Koob, A.O., and Borgens, R.B., 2006. Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons. Journal of Neuroscience Research, 83 (8), 1558–1563.
   PubMed Web of Science ®Google Scholar
• Kornev, V.A., et al., 2018. Hydrogel-assisted neuroregeneration approaches towards brain injury therapy: a state-of-the-art review. Computational and Structural Biotechnology Journal, 16, 488–502.
   PubMed Web of Science ®Google Scholar
• Kronenberg, S., et al., 2013. Current challenges and opportunities in nonclinical safety testing of biologics. Drug Discovery Today, 18 (23–24), 1138–1143.
   PubMed Web of Science ®Google Scholar
• Lampe, K. J., et al., 2010. Effect of macromer weight percent on neural cell growth in 2D and 3D nondegradable PEG hydrogel culture. Journal of Biomedical Materials Research Part A, 9999A, NA–NA. 10.1002/jbm.a.32787
   Google Scholar
• Lampe, K.J., et al., 2011. The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: protein distribution and the glial response. Journal of Biomedical Materials Research Part A, 96A (3), 595–607.
   Web of Science ®Google Scholar
• Liu, X., et al., 2018. Construction of fluorescein isothiocyanate-labeled MSNs/PEG/Lycorine/Antibody as drug carrier for targeting prostate cancer cells. Journal of Nanoscience and Nanotechnology, 18 (7), 4471–4477.
   PubMed Web of Science ®Google Scholar
• Lundgaard, I., et al., Nedergaard, M., 2018. Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function. Scientific Reports, 8 (1), 2246.
   PubMedGoogle Scholar
• Mendiola, A.S., and Cardona, A.E., 2018. The IL-1β phenomena in neuroinflammatory diseases. Journal of Neural Transmission, 125 (5), 781–795.
   PubMed Web of Science ®Google Scholar
• Prentice, D.E., and Majeed, S.K., 1978. Oral toxicity of polyethylene glycol (PEG 200) in monkeys and rats. Toxicology Letters, 2 (2), 119–122.
   Web of Science ®Google Scholar
• Rowe, R. C. (Ed.). 2009. Handbook of pharmaceutical excipients. 6th ed. London: APhA, (PhP) Pharmaceutical Press.
   Google Scholar
• Rudmann, D.G., et al., 2013. High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins. Toxicologic Pathology, 41 (7), 970–983.
   PubMed Web of Science ®Google Scholar
• Saenger, S., et al., 2011. PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders. Growth Hormone & Igf Research, 21 (5), 292–303.
   PubMed Web of Science ®Google Scholar
• Santos, N.C., et al., 2003. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochemical Pharmacology, 65 (7), 1035–1041.
   PubMed Web of Science ®Google Scholar
• Savage, J.C., Carrier, M., and Tremblay, M.-È., 2019. Morphology of microglia across contexts of health and disease. Methods in Molecular Biology (Clifton, N.J. ), 2034, 13–26.
   PubMedGoogle Scholar
• Smyth, H.F., Carpenter, C.P., and Weil, C.S., 1955. The chronic oral toxicology of thepolyethylene glycols*. Journal of the American Pharmaceutical Association (Scientific Ed), 44 (1), 27–30.
   Google Scholar
• Sofroniew, M.V., and Vinters, H.V., 2010. Astrocytes: biology and pathology. Acta Neuropathologica, 119 (1), 7–35.
   PubMed Web of Science ®Google Scholar
• Streit, W.J., et al., 2004. Dystrophic microglia in the aging human brain. Glia, 45 (2), 208–212.
   PubMed Web of Science ®Google Scholar
• Szebeni, J., 2005. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology, 216 (2–3), 106–121.
   PubMed Web of Science ®Google Scholar
• Tamariz, E., et al., Castaño, V.M., 2011. Delivery of chemotropic proteins and improvement of dopaminergic neuron outgrowth through a thixotropic hybrid nano-gel. Journal of Materials Science. Materials in Medicine, 22 (9), 2097–2109.
   PubMed Web of Science ®Google Scholar
• Thiele, W., et al., 2019. A cautionary note: toxicity of polyethylene glycol 200 injected intraperitoneally into mice. Laboratory Animals, 54 (4), 391–396.
   PubMed Web of Science ®Google Scholar
• Vasile, F., Dossi, E., and Rouach, N., 2017. Human astrocytes: structure and functions in the healthy brain. Brain Structure & Function, 222 (5), 2017–2029.
   PubMed Web of Science ®Google Scholar
• Veronese Francesco. 2002. Introduction and overview of peptide and protein pegylation. Advanced Drug Delivery Reviews, 54 (4), 453–456.
   PubMed Web of Science ®Google Scholar
• Wagner, S., et al., Wolff, J.E.A., 2008. Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors. Journal of Neuro-Oncology, 86 (2), 175–181.
   PubMed Web of Science ®Google Scholar
• Wang, L.-L., et al., Chen, Y.-Y., 2016. Resveratrol attenuates inflammatory hyperalgesia by inhibiting glial activation in mice spinal cords. Molecular Medicine Reports, 13 (5), 4051–4057.
   PubMed Web of Science ®Google Scholar
• Worthley, E. G., and Schott, C. D., 1965. Pharmacotoxic Evaluation Of Nine Vehicles Administered Intraperitoneally To Mice. Fort Belvoir, VA: Defense Technical Information Center. http://www.dtic.mil/docs/citations/AD0628313
   Google Scholar
• Yemişci, M., et al., 2012. Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles. Methods in Enzymology, 508, 253–269.
   PubMed Web of Science ®Google Scholar
• Yue, J., et al., 2012. Fluorescence-labeled immunomicelles: preparation, in vivo biodistribution, and ability to cross the blood-brain barrier. Macromolecular Bioscience, 12 (9), 1209–1219.
   PubMed Web of Science ®Google Scholar